Ketamine in Major Depressive Disorder: Mechanisms and Future Perspectives
Cheolmin Shin, Yong-Ku Kim
Psychiatry Investig. 2020;17(3):181-192.   Published online 2020 Mar 23     DOI: https://doi.org/10.30773/pi.2019.0236
Menin Reduces Parvalbumin Expression and is Required for the Anti‐Depressant Function of Ketamine
Lige Leng, Kai Zhuang, Hui Lin, Jinjun Ding, Shangchen Yang, Ziqi Yuan, Changquan Huang, Guimiao Chen, Zhenlei Chen, Mengdan Wang, Han Wang, Hao Sun, Huifang Li, He Chang, Zhenyi Chen, Qi Xu, Tifei Yuan, Jie Zhang
Advanced Science.2024;[Epub]     CrossRef
Using an Interpretable Amino Acid-Based Machine Learning Method to Enhance the Diagnosis of Major Depressive Disorder
Cyrus Su Hui Ho, Trevor Wei Kiat Tan, Howard Cai Hao Khoe, Yee Ling Chan, Gabrielle Wann Nii Tay, Tong Boon Tang
Journal of Clinical Medicine.2024; 13(5): 1222.     CrossRef
Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial
Ahmad Zolghadriha, Afagh Anjomshoaa, Mohammad Reza Jamshidi, Farnaz Taherkhani
BMC Psychiatry.2024;[Epub]     CrossRef
Ketamine in the effective management of chronic pain, depression, and posttraumatic stress disorder for Veterans: A meta-analysis and systematic review
Jenny J.W. Liu, Natalie Ein, Julia Gervasio, Clara Baker, Rachel Plouffe, Sonya Wanklyn, Amer M. Burhan, Brenda Lau, Emmanuel Abreu, Thomas Wasiuta, Anthony Nazarov, J. Don Richardson
Frontiers in Psychiatry.2024;[Epub]     CrossRef
Evaluation of thoracic sympathetic ganglion block as a predictor for response to ketamine infusion therapy and spinal cord stimulation in patients with chronic upper extremity pain
Jeongsoo Kim, Hangaram Kim, Jae Eun Kim, Yongjae Yoo, Jee Youn Moon
Pain Medicine.2024;[Epub]     CrossRef
Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A
Frederick A. Bagdasarian, Hanne D. Hansen, Jingyuan Chen, Chi-Hyeon Yoo, Michael S. Placzek, Jacob M. Hooker, Hsiao-Ying Wey
ACS Chemical Neuroscience.2024;[Epub]     CrossRef
Major challenges in youth psychopathology: treatment-resistant depression. A narrative review
Giulia Menculini, Gianmarco Cinesi, Francesca Scopetta, Matteo Cardelli, Guido Caramanico, Pierfrancesco Maria Balducci, Filippo De Giorgi, Patrizia Moretti, Alfonso Tortorella
Frontiers in Psychiatry.2024;[Epub]     CrossRef
Molecular pathways of major depressive disorder converge on the synapse
Gabriel R. Fries, Valeria A. Saldana, Johannes Finnstein, Theo Rein
Molecular Psychiatry.2023; 28(1): 284.     CrossRef
Retrospective data analysis to determine the effectiveness of intravenous ketamine therapy on patients suffering from depression with suicidal ideation
Pradhyuman Chaudhary, Prathmesh Shah, Prakash Mehta
Industrial Psychiatry Journal.2023; 32(1): 86.     CrossRef
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment‐resistant depression
Giovanni Martinotti, Bernardo Dell'Osso, Giorgio Di Lorenzo, Giuseppe Maina, Alessandro Bertolino, Massimo Clerici, Stefano Barlati, Gianluca Rosso, Marco Di Nicola, Matteo Marcatili, Giacomo d'Andrea, Clara Cavallotto, Stefania Chiappini, Sergio De Filip
Bipolar Disorders.2023; 25(3): 233.     CrossRef
Ketamine Reduces the Surface Density of the Astroglial Kir4.1 Channel and Inhibits Voltage-Activated Currents in a Manner Similar to the Action of Ba2+ on K+ Currents
Mićo Božić, Samo Pirnat, Katja Fink, Maja Potokar, Marko Kreft, Robert Zorec, Matjaž Stenovec
Cells.2023; 12(10): 1360.     CrossRef
Dynamic regulation of the extracellular matrix in reward memory processes: a question of time
Jake Valeri, Barbara Gisabella, Harry Pantazopoulos
Frontiers in Cellular Neuroscience.2023;[Epub]     CrossRef
Increase in thalamic cerebral blood flow is associated with antidepressant effects of ketamine in major depressive disorder
Matti Gärtner, Mischa de Rover, Lena Václavů, Milan Scheidegger, Matthias J. P. van Osch, Simone Grimm
The World Journal of Biological Psychiatry.2022; 23(8): 643.     CrossRef
Ketamine sex- and dose-dependently mitigates behavioral sequelae induced by a predator-based psychosocial stress model of post-traumatic stress disorder
Phillip R. Zoladz, Colin R. Del Valle, Cassandra S. Goodman, Jordan L. Dodson, Ian F. Smith, Kara M. Elmouhawesse, Heather R. Sparkman, Margaret M. Naylor, Elizabeth P. Hopson
Behavioural Brain Research.2022; 428: 113895.     CrossRef
Potential Synergy of Lithium and Ketamine in Treatment of Recurrent Major Depression
Tony Sun, Dimitry Francois
Psychiatric Annals.2022; 52(4): 170.     CrossRef
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study)
Giovanni Martinotti, Antonio Vita, Andrea Fagiolini, Giuseppe Maina, Alessandro Bertolino, Bernardo Dell'Osso, Alberto Siracusano, Massimo Clerici, Antonello Bellomo, Gabriele Sani, Giacomo d'Andrea, Roberto Delle Chiaie, Andreas Conca, Stefano Barlati, G
Journal of Affective Disorders.2022; 319: 646.     CrossRef
The role of immunomodulators in treatment-resistant depression: case studies
Charles W. Beckett, Maria Victoria Niklison-Chirou
Cell Death Discovery.2022;[Epub]     CrossRef
Ketamine specifically reduces cognitive symptoms in depressed patients: An investigation of associated neural activation patterns
A. Stippl, M. Scheidegger, S. Aust, A. Herrera, M. Bajbouj, M. Gärtner, S. Grimm
Journal of Psychiatric Research.2021; 136: 402.     CrossRef
Crosstalk between Existential Phenomenological Psychotherapy and Neurological Sciences in Mood and Anxiety Disorders
Lehel Balogh, Masaru Tanaka, Nóra Török, László Vécsei, Shigeru Taguchi
Biomedicines.2021; 9(4): 340.     CrossRef
Striatal Shati/Nat8l–BDNF pathways determine the sensitivity to social defeat stress in mice through epigenetic regulation
Hajime Miyanishi, Shin-ichi Muramatsu, Atsumi Nitta
Neuropsychopharmacology.2021; 46(9): 1594.     CrossRef
A Role of BDNF in the Depression Pathogenesis and a Potential Target as Antidepressant: The Modulator of Stress Sensitivity “Shati/Nat8l-BDNF System” in the Dorsal Striatum
Hajime Miyanishi, Atsumi Nitta
Pharmaceuticals.2021; 14(9): 889.     CrossRef
Major Depressive Disorder: Current Advances and Paradigm Shifts
Yong-Ku Kim
Psychiatry Investigation.2020; 17(3): 179.     CrossRef
Ketamine: a versatile tool for anesthesia and analgesia
William Barrett, Michael Buxhoeveden, Sabrina Dhillon
Current Opinion in Anaesthesiology.2020; 33(5): 633.     CrossRef